adapted application s nyubellevue adult aids clinical trials unit propose investigate new candidate drugs design potent combination regimens using existing agents ultimate goals suppressing hiv replication cellular anatomic compartments infected individuals eliminating latently infected cells achieving goals requires increase understanding virologic host immunologic factors governing pathogenesis hiv disease actu proposes methods increase effectiveness therapeutic regimens ease drugs taken decreasing side effects unit also proposes work improve prevention treatment complications hiv infection unit ability immunopathogenesis disease modulate immune responses hiv actu investigate combinations antiretroviral therapy immunotherapy potential establishing immunological control hiv infection similar presumed present longterm nonprogressors unit states tradition generating highest possible quality data enabling medically underserved minorities access newest experimental therapies proposes continue work